FREDA HUBBARD: Open Payments
NPI 1508168873 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,410 in 82 payments from 23 companies in 2025. Trend: 2023 $2,119 · 2024 $1,399 · 2025 $1,410
Food & beverage: $1,410
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $270 |
| PFIZER INC. | 11 | $218 |
| ABBVIE INC. | 13 | $198 |
| Lilly USA, LLC | 13 | $179 |
| Kestra Medical Technology Services, Inc. | 1 | $88 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $88 |
| Amgen Inc. | 3 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Stryker Corporation | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
Products named: UBRELVY, MOUNJARO, Wegovy, NURTEC ODT, ELIQUIS, Assure WCD, CAPLYTA, TRINTELLIX.
Industry payments across KY — which companies pay providers there.
